logo

For the Inventor, By the Inventor

Alzenau, Germany

Jürgen Engel

This inventor holds 15 USPTO granted patents, primarily in Pharmaceutical Compositions. Top assignees: Asta Medica, Aktiengesellschaft, Zentaris Ag, Zentaris Gmbh. Active years: 2001-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jürgen Engel. Retrieved from https://idiyas.com/inventor/janduumlrgen-engel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15

% Patents Active = 86.7

Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 108(Granted Patents)


Company Filing History:

goldMedal4 out of 112 
 
Asta Medica, Aktiengesellschaft
 patents
silverMedal4 out of 20 
 
Zentaris Ag
 patents
bronzeMedal2 out of 22 
 
Zentaris Gmbh
 patents
4. 1 out of 29 
 
Asta Pharma Aktiengesellschaft
 patents
5. 1 out of 1,203 
 
Baxter Healthcare Sa
 patents
6. 1 out of 8 
 
Viatris Gmbh & Co Kg
 patents
7. 2 out of 834,659 
Other
 patents

Years Active: 2001-2004

Loading Chart...
Areas of Expertise:
Oligopeptide Lyophilisate
Dopamine Receptor Antagonists
Peptide Salts
Palliative Tumor Therapy
Therapeutic Phospholipid Derivatives
Prostate Cancer
Migraine Treatment
Fertility Disorders
Flupirtine
Protozoal Diseases
R-α-Lipoic Acid
S-α-Lipoic Acid
15 patents (USPTO):Explore Patents
1. 6828415 - Oligopeptide lyophilisate, their preparation and use (2004-12-07),
2. 6780972 - Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts (2004-08-24),
3. 6716817 - Method of treatment of female infertility (2004-04-06),
4. 6696428 - Use of dopamine receptor antagonists in palliative tumor therapy (2004-02-24),
5. 6693119 - Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties (2004-02-17),
6. 6667058 - Oral forms of administration containing solid flupirtine with controlled release of active substance (2003-12-23),
7. 6576624 - Use of dopamine receptor antagonists in palliative tumor therapy (2003-06-10),
8. 6506393 - Methods of treating protozoal diseases (2003-01-14),
9. 6479472 - Methods of using therapeutic phospholipid derivatives (2002-11-12),
10. 6436924 - Antihistamine leukotriene combinations (2002-08-20),
11. 6319192 - Method for the treatment of fertility disorders (2001-11-20),
12. 6300313 - Means for treating prostate hypertrophy and prostate cancer (2001-10-09),
13. 6271254 - Pharmaceutical compositions containing R-&agr;-lipoic acid or S-&agr;-lipoic acid as active ingredient (2001-08-07),
14. 6254879 - Methods of treating protozoal diseases (2001-07-03),
15. 6251935 - Treatment of migraine by administration of &agr;-lipoic acid or derivatives thereof (2001-06-26),

Title: Jürgen Engel: Innovator in Peptide Technology

Introduction

Jürgen Engel is a prominent inventor based in Alzenau, Germany. He has made significant contributions to the field of peptide technology, holding a total of 15 patents. His work focuses on innovative methods and applications that have the potential to impact medical treatments.

Latest Patents

Among his latest patents is the development of an oligopeptide lyophilisate, which includes a novel method of preparation and its use in treating female infertility and for gonad protection. This lyophilizate is created by dissolving Cetrorelix in a 30% v/v acetic acid solution, which is then transferred to water and freeze-dried. Another significant patent involves a method for synthesizing peptide salts, which details the process of reacting an acid addition salt of a basic starting peptide in the presence of a diluent using a mixed bed ion exchanger. This method allows for the formation of a free basic peptide, followed by the separation of the ion exchanger and the desired acid addition salt of the peptide.

Career Highlights

Jürgen Engel has worked with notable companies in the pharmaceutical industry, including Asta Medica and Zentaris AG. His experience in these organizations has contributed to his expertise in peptide research and development.

Collaborations

Throughout his career, Jürgen has collaborated with esteemed colleagues such as Bernd Nickel and Thomas Klenner. These partnerships have fostered innovation and advancement in his field.

Conclusion

Jürgen Engel's contributions to peptide technology and his innovative patents highlight his role as a leading inventor in the medical field. His work continues to pave the way for advancements in treatments for various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…